Xiaochun Zhang

954 total citations
33 papers, 621 citations indexed

About

Xiaochun Zhang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xiaochun Zhang has authored 33 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Xiaochun Zhang's work include Lung Cancer Research Studies (11 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Treatments and Mutations (6 papers). Xiaochun Zhang is often cited by papers focused on Lung Cancer Research Studies (11 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Lung Cancer Treatments and Mutations (6 papers). Xiaochun Zhang collaborates with scholars based in China and United States. Xiaochun Zhang's co-authors include Helei Hou, Dantong Sun, Man Jiang, Li Wang, Jialin Qu, Deze Zhao, Na Zhou, Kang Qin, Helei Hou and Jingjuan Zhu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Xiaochun Zhang

30 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaochun Zhang China 15 293 238 155 115 99 33 621
Jinchul Kim South Korea 10 234 0.8× 243 1.0× 123 0.8× 175 1.5× 159 1.6× 31 633
Qingyang Gu China 13 235 0.8× 350 1.5× 114 0.7× 62 0.5× 151 1.5× 26 666
Xueying Wang China 8 212 0.7× 260 1.1× 95 0.6× 123 1.1× 128 1.3× 29 683
Sabrina Vari Italy 13 272 0.9× 435 1.8× 186 1.2× 55 0.5× 196 2.0× 30 800
Guido Giordano Italy 16 493 1.7× 267 1.1× 179 1.2× 129 1.1× 225 2.3× 76 916
Songtao Lai China 11 251 0.9× 314 1.3× 90 0.6× 105 0.9× 168 1.7× 21 645
Faezeh Khodadadi Iran 4 470 1.6× 197 0.8× 135 0.9× 265 2.3× 60 0.6× 6 749
Habib Sadeghirad Australia 7 509 1.7× 238 1.0× 146 0.9× 298 2.6× 82 0.8× 14 837
Sharon Glaysher United Kingdom 16 286 1.0× 324 1.4× 143 0.9× 54 0.5× 112 1.1× 30 690

Countries citing papers authored by Xiaochun Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiaochun Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochun Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochun Zhang more than expected).

Fields of papers citing papers by Xiaochun Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaochun Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochun Zhang. The network helps show where Xiaochun Zhang may publish in the future.

Co-authorship network of co-authors of Xiaochun Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaochun Zhang. A scholar is included among the top collaborators of Xiaochun Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaochun Zhang. Xiaochun Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Liu, Huamin, Xiaochun Zhang, Shaoli Wang, et al.. (2023). Role of uric acid as a biomarker of cognitive function in schizophrenia during maintenance period. Frontiers in Psychiatry. 14. 1123127–1123127. 5 indexed citations
4.
Jiang, Man, Chuantao Zhang, Guangjie Yang, et al.. (2022). Anlotinib Combined with Toripalimab as Second-Line Therapy for Advanced, Relapsed Gastric or Gastroesophageal Junction Carcinoma. The Oncologist. 27(11). e856–e869. 13 indexed citations
5.
Jiang, Man, Tianjun Li, Guanqun Wang, & Xiaochun Zhang. (2022). Efficacy and safety of pembrolizumab in combination with anlotinib in the treatment of refractory or recurrent high-grade serous ovarian cancer: A phase 2 nonrandomized clinical trial.. Journal of Clinical Oncology. 40(16_suppl). 5543–5543.
6.
Zhang, Xiaochun, Desheng Huang, & Peng Guan. (2021). Nursing Scheduling Mode and Experience from the Medical Teams in Aiding Hubei Province During the COVID-19 Outbreak: A Systematic Scoping Review of 17 Studies. Risk Management and Healthcare Policy. Volume 14. 1805–1813. 7 indexed citations
7.
8.
9.
Wang, Hongxia, Liyan Wang, Yanning Li, et al.. (2021). Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells. Cancer Cell International. 21(1). 450–450. 22 indexed citations
10.
Yang, Lu-Ping, Zixian Wang, Rui Zhang, et al.. (2021). Association between cigarette smoking and colorectal cancer sidedness: A multi-center big-data platform-based analysis. Journal of Translational Medicine. 19(1). 150–150. 14 indexed citations
11.
Chen, Chu, et al.. (2020). Anlotinib is effective in patients with advanced oral cancer?. Medical Hypotheses. 137. 109578–109578. 3 indexed citations
12.
Wang, Yun, Man Jiang, Jingjuan Zhu, et al.. (2020). The safety and efficacy of lenvatinib combined with immune checkpoint inhibitors therapy for advanced hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 132. 110797–110797. 43 indexed citations
13.
Wang, Li, Jialin Qu, Na Zhou, et al.. (2020). Effect and biomarker of immune checkpoint blockade therapy for ARID1A deficiency cancers. Biomedicine & Pharmacotherapy. 130. 110626–110626. 24 indexed citations
14.
Qu, Jialin, Li Wang, Man Jiang, et al.. (2020). <p>A Review About Pembrolizumab in First-Line Treatment of Advanced NSCLC: Focus on KEYNOTE Studies</p>. Cancer Management and Research. Volume 12. 6493–6509. 27 indexed citations
15.
Qu, Jialin, Man Jiang, Li Wang, et al.. (2020). Mechanism and potential predictive biomarkers of immune checkpoint inhibitors in NSCLC. Biomedicine & Pharmacotherapy. 127. 109996–109996. 35 indexed citations
16.
Wang, Li, Na Zhou, Jialin Qu, Man Jiang, & Xiaochun Zhang. (2020). Identification of an RNA binding protein-related gene signature in hepatocellular carcinoma patients. Molecular Medicine. 26(1). 125–125. 15 indexed citations
17.
Wang, Li, Deze Zhao, Kang Qin, Faisal Rehman, & Xiaochun Zhang. (2019). Effect and biomarker of Nivolumab for non–small-cell lung cancer. Biomedicine & Pharmacotherapy. 117. 109199–109199. 25 indexed citations
18.
Hou, Helei, Dantong Sun, & Xiaochun Zhang. (2019). The role of MDM2 amplification and overexpression in therapeutic resistance of malignant tumors. Cancer Cell International. 19(1). 216–216. 162 indexed citations
19.
Zhang, Xiaochun, Bingliang Fang, Radhe Mohan, & Joe Y. Chang. (2012). Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer. Radiotherapy and Oncology. 105(2). 250–257. 14 indexed citations
20.
Cheung, Rex, et al.. (2005). Characterizing the interaction between radiation sensitivity and epidermal growth factor receptor inhibition in prostate cancer cell lines. Cancer Research. 65. 228–229.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinchul Kim Breakdown of academic impact, for papers by Qingyang Gu Breakdown of academic impact, for papers by Xueying Wang Breakdown of academic impact, for papers by Sabrina Vari Breakdown of academic impact, for papers by Guido Giordano Breakdown of academic impact, for papers by Songtao Lai Breakdown of academic impact, for papers by Faezeh Khodadadi Breakdown of academic impact, for papers by Habib Sadeghirad Breakdown of academic impact, for papers by Sharon Glaysher
Rankless by CCL
2026